ImmuSmol team combines 25 years of experience in the design and development of small molecule antibodies. Our R&D activities also involve a worldwide network of scientific consultants and collaborators, bringing expertise in areas such as chemistry, immunology, oncology and neuroscience.
Alban Bessede, PhD Founder,
Chief Executive Officer
Born and bred in Bordeaux, Alban founded ImmuSmol immediately after a post-doc in Sydney. Trained in immunology, he gained expertise in small molecule antibodies in the course of his research in oncology and neurodegeneration, eventually leading him to envisage their use in diagnostics and therapy.
Board of directors
Vincent Picq, MSc
Founder, Chairman of Schiever
Vincent Picq has been supporting ImmuSmol since the very beginning. Head of a retailing group with annual sales exceeding €1,3 billion, he is providing ImmuSmol with strategic, management and administrative support.